Categories: HealthcareNews

Sheila Savageau Joins the IntoValue Board of Directors

A national leader in direct to employer healthcare arrangements joins IntoValue Board

WASHINGTON, DC / ACCESSWIRE / August 19, 2024 / IntoValue, Inc, a trailblazing healthcare direct-to-employer enablement company, proudly announces the appointment of Sheila Savageau to its Board of Directors.

Sheila Savageau
A national leader in direct to employer healthcare innovation, Sheila Savage

Sheila Savageau brings a wealth of experience to IntoValue, currently serving as the Director of Benefits and Rewards Operations at General Motors. Previously, Sheila held the role of Global Health and Well-being Leader, where she played a pivotal role in establishing and executing General Motors’ healthcare strategy through innovative healthcare delivery models. Her advocacy for improving member experiences, driving engagement in healthcare systems, and enhancing healthcare quality for GM employees and their families has garnered widespread acclaim.

Notably, under Sheila’s leadership, General Motors pioneered the strategy and delivery of the first value-based direct contract with Henry Ford Health System in 2019, marking a significant milestone in direct-to-employer partnerships. Sheila continues to spearhead value-based initiatives in various markets and remains an active member of prominent employer coalitions, including the National Alliance of Healthcare, Business Group on Health, Corporate Health Care Coalition, and the Economic Alliance of Michigan.

Commenting on Sheila’s appointment, Dr. Marion Couch, CEO of IntoValue, expressed admiration, stating, “Sheila is a true pioneer in direct-to-employer partnerships, exemplified by her instrumental role in the successful GM – Henry Ford Health System contract. Her expertise and vision for a better healthcare system are invaluable assets to IntoValue, inspiring us every day.”

In response to her appointment, Sheila Savageau expressed enthusiasm, stating, “I am excited to join the IntoValue team as a founding Board member. Direct-to-employer arrangements hold immense potential in improving healthcare outcomes while reducing costs. I look forward to leveraging my experience to drive positive change with IntoValue.”

About IntoValue, Inc:

IntoValue, Inc, headquartered in Washington, DC, is a pioneering technology-enabled direct-to-employer enablement company. Committed to revolutionizing healthcare delivery, IntoValue partners directly with health systems and self-insured employers. The company’s mission is to establish advanced primary care and regional centers of excellence programs, fostering improved employee health and community wellness. IntoValue empowers providers with a cutting-edge data analytics platform featuring predictive AI capabilities, fostering equitable data sharing between employers and providers.

For media inquiries or further information, please contact:

www.Intovaluegroup.com

Contact Information

Marion Couch
CEO
marion.couch@intovaluegroup.com
317-450-9119

SOURCE: IntoValue, Inc

View the original press release on newswire.com.

Staff

Recent Posts

Olympian Gabby Thomas Draws Crowd at Wellness Event with BetterWay(TM) Blood Testing at H-E-B SoCo

Guests had an opportunity to meet Gabby Thomas, win health-focused prizes, and learn simple ways…

3 hours ago

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

12 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

15 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

15 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

15 hours ago